BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26232226)

  • 1. Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways.
    Gonzales KA; Liang H; Lim YS; Chan YS; Yeo JC; Tan CP; Gao B; Le B; Tan ZY; Low KY; Liou YC; Bard F; Ng HH
    Cell; 2015 Jul; 162(3):564-79. PubMed ID: 26232226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells.
    Zhu H; Hu S; Baker J
    Stem Cells; 2014 Aug; 32(8):2098-110. PubMed ID: 24740926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition.
    Choi HS; Lee HM; Jang YJ; Kim CH; Ryu CJ
    Stem Cells; 2013 Dec; 31(12):2647-58. PubMed ID: 23495120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formula G1: Cell cycle in the driver's seat of stem cell fate determination.
    Julian LM; Carpenedo RL; Rothberg JL; Stanford WL
    Bioessays; 2016 Apr; 38(4):325-32. PubMed ID: 26857166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lengthened G1 phase indicates differentiation status in human embryonic stem cells.
    Calder A; Roth-Albin I; Bhatia S; Pilquil C; Lee JH; Bhatia M; Levadoux-Martin M; McNicol J; Russell J; Collins T; Draper JS
    Stem Cells Dev; 2013 Jan; 22(2):279-95. PubMed ID: 22827698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.
    Atkinson S; Armstrong L
    Cell Tissue Res; 2008 Jan; 331(1):23-9. PubMed ID: 18004593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56.
    Jain AK; Xi Y; McCarthy R; Allton K; Akdemir KC; Patel LR; Aronow B; Lin C; Li W; Yang L; Barton MC
    Mol Cell; 2016 Dec; 64(5):967-981. PubMed ID: 27912097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms controlling the cell cycle in embryonic stem cells.
    Abdelalim EM
    Stem Cell Rev Rep; 2013 Dec; 9(6):764-73. PubMed ID: 23955576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide reduction in H3K9 acetylation during human embryonic stem cell differentiation.
    Krejcí J; Uhlírová R; Galiová G; Kozubek S; Smigová J; Bártová E
    J Cell Physiol; 2009 Jun; 219(3):677-87. PubMed ID: 19202556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulation in human embryonic stem cells: links to adaptation to cell culture.
    Barta T; Dolezalova D; Holubcova Z; Hampl A
    Exp Biol Med (Maywood); 2013 Mar; 238(3):271-5. PubMed ID: 23598972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-290-295 cluster promotes pluripotency maintenance by regulating cell cycle phase distribution in mouse embryonic stem cells.
    Lichner Z; Páll E; Kerekes A; Pállinger E; Maraghechi P; Bosze Z; Gócza E
    Differentiation; 2011 Jan; 81(1):11-24. PubMed ID: 20864249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human embryonic stem cells exhibit increased propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein.
    Sela Y; Molotski N; Golan S; Itskovitz-Eldor J; Soen Y
    Stem Cells; 2012 Jun; 30(6):1097-108. PubMed ID: 22415928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The alchemy--epigenetic regulation of pluripotency].
    Bem J; Grabowska I
    Postepy Biochem; 2013; 59(2):144-56. PubMed ID: 24044279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1.
    Edel MJ; Menchon C; Menendez S; Consiglio A; Raya A; Izpisua Belmonte JC
    Genes Dev; 2010 Mar; 24(6):561-73. PubMed ID: 20231315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms involved in self-renewal and pluripotency of embryonic stem cells.
    Liu N; Lu M; Tian X; Han Z
    J Cell Physiol; 2007 May; 211(2):279-86. PubMed ID: 17195167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of signalling pathway inhibitors and chromatin modifiers for enhancing pluripotency.
    Sumer H; Liu J; Verma PJ
    Theriogenology; 2010 Sep; 74(4):525-33. PubMed ID: 20615537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks.
    Boward B; Wu T; Dalton S
    Stem Cells; 2016 Jun; 34(6):1427-36. PubMed ID: 26889666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs in stem cell pluripotency.
    Ng SY; Stanton LW
    Wiley Interdiscip Rev RNA; 2013; 4(1):121-8. PubMed ID: 23139157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt1, p53, and p38(MAPK) are crucial regulators of detrimental phenotypes of embryonic stem cells with Max expression ablation.
    Hishida T; Nozaki Y; Nakachi Y; Mizuno Y; Iseki H; Katano M; Kamon M; Hirasaki M; Nishimoto M; Okazaki Y; Okuda A
    Stem Cells; 2012 Aug; 30(8):1634-44. PubMed ID: 22696478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells.
    Neganova I; Zhang X; Atkinson S; Lako M
    Oncogene; 2009 Jan; 28(1):20-30. PubMed ID: 18806832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.